Emerging data from the management of patients with coronavirus disease 2019 (COVID‐19)
suggests multi‐systemic involvement, including the hemopoietic system. The …

The γδT cell subset of peripheral lymphocytes exhibits potent cancer antigen recognition
independent of classical peptide MHC complexes, making it an attractive candidate for …

Immunoglobulin D (IgD) myeloma is a subtype often considered to have adverse features
and inferior survival, but there is a paucity of data from large clinical studies. We compare the …

Solitary plasmacytoma is a rare localised neoplasm of monoclonal plasma cells. The
standard treatment involves radical radiotherapy; however, a significant proportion of patients …

Unstable hemoglobins (Hbs) are often overlooked in the differential diagnoses of drug-induced
hemolysis. Hb Peterborough [β111(G13)Val→Phe; HBB: c.334G>T] is a rare unstable Hb …

The investigation of conventional complete blood-count (CBC) data for classifying the SARS-CoV-2
infection status became a topic of interest, particularly as a complementary …

A novel highly pathogenic human corona virus (COVID19) has been recently recognised in
Wuhan, China as the cause of corona disease outbreak. It has rapidly spread from China to …

A novel highly pathogenic human corona virus (COVID19) has been recently recognised in
Wuhan, China as the cause of corona disease outbreak. It has rapidly spread from China to …

Pregnant women are among the high-risk population for severe coronavirus disease 2019 (COVID-19)
with unfavorable peripartum outcomes and increased incidence of preterm births. …

T cell-based cancer immunotherapy has typically relied on membrane-bound cytotoxicity
enhancers such as chimeric antigen receptors expressed in autologous αβT cells. These …